Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk

21.01.25 14:45 Uhr

Werte in diesem Artikel
Aktien

11,00 EUR -0,10 EUR -0,90%

LINCOLN, Neb., Jan. 21, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food security solutions, announced today the launch of Igenity® BCHF to improve overall bovine heart health standards.

Neogen Corporation (PRNewsfoto/Neogen Corporation)

Bovine Congestive Heart Failure (BCHF) stands as a significant threat to cattle health and productivity, and this genomic test provides a new opportunity for improved selection for heart health. Testing with Igenity BCHF assesses an animal's genetic predisposition for BCHF, scored on a 1-to-10 scale. Ranging from 1 (lowest risk) to 10 (highest risk of disease development), each decreased score on the scale as an approximately 3.5% lower expected incidence rate for BCHF.

"Igenity BCHF is a revolutionary genomic test designed to assess an animal's genetic predisposition to heart failure," says Victor Pedrosa, Ph.D., Director of Technical Genomics and Innovation at Neogen. "The test results directly correlate with the percentage of BCHF risk an animal carries and could pass on to their progeny, serving as a genetic indicator of the likelihood of disease development."

BCHF presents a growing threat to the health and productivity of all segments of the cattle industry, from young calves on the pasture to late-fed cattle. Igenity BCHF provides producers with the opportunity to more effectively manage the risk of BCHF within their herd, confidently produce feeder calves that will have a lower risk of mortality from BCHF in a feedlot setting, and decrease economic losses attributed to BCHF.

"When we look at the impact of Igenity BCHF on the industry, it is helping to genetically quantify the risk for bovine congestive heart failure and progress herds away from this growing cattle health and welfare concern," says Kirk Ramsey, DVM, Professional Services Veterinarian with Neogen. "Igenity BCHF is the first genomic test of its kind and is the first step in capturing the reason why congestive heart failure is occurring in these young calves and late-fed cattle."

To learn more about Igenity BCHF, visit neogen.com/igenity-beef or contact your Neogen representative.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Media Contact

PR@Neogen.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-introduces-igenity-bchf-to-help-industry-mitigate-bovine-congestive-heart-failure-risk-302355664.html

SOURCE Neogen Corporation

Ausgewählte Hebelprodukte auf Neogen

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Neogen

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Neogen Corp.

Wer­bung

Analysen zu Neogen Corp.

DatumRatingAnalyst
31.03.2011Neogen neutralJ.J.B. Hilliard, W.L. Lyons, Inc.
22.07.2009Neogen buyROTH Capital Partners, LLC
20.03.2009Neogen buyROTH Capital Partners, LLC
07.01.2009Neogen Kursziel gesenktROTH Capital Partners, LLC
26.09.2008Neogen neues KurszielROTH Capital Partners, LLC
DatumRatingAnalyst
22.07.2009Neogen buyROTH Capital Partners, LLC
20.03.2009Neogen buyROTH Capital Partners, LLC
07.01.2009Neogen Kursziel gesenktROTH Capital Partners, LLC
26.09.2008Neogen neues KurszielROTH Capital Partners, LLC
04.01.2008Neogen neues KurszielROTH Capital Partners, LLC
DatumRatingAnalyst
31.03.2011Neogen neutralJ.J.B. Hilliard, W.L. Lyons, Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogen Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"